Confirmed speakers for the 2022 Global Annual Meeting of the Medical Affairs Professional Society (MAPS)


Medical Affairs Professional Society (MAPS) Global Annual Meeting 2022

Over 500 medical affairs professionals will gather in New Orleans March 20-23, 2022 for the largest annual gathering FOR Medical Affairs, BY Medical Affairs

From Vision to Action – Now is the time to lead for Medical Affairs ”

– PLANS

GOLDEN, COLO, USA, Oct 21, 2021 /EINPresswire.com/ – The Medical Affairs Professional Society (MAPS) is delighted to announce the speakers for the MAPS Global Annual Meeting, to be held in New Orleans, in Louisiana, March 20-23. 2022. The event is the largest annual gathering of medical business professionals, with over 500 medical business professionals from around the world gathered for this one-of-a-kind event developed for medical affairs by Medical Affairs. Early registration for individuals and teams is open until November 19, 2021. Now is the watershed moment for medical affairs as we fully realize our place as a strategic pillar in the biopharmaceutical and MedTech industries. The theme for the 2022 Global Annual Meeting, “From Vision to Action – The Time for Medical Affairs is Now”, reflects the pivotal moment in which medical professionals find themselves following the pandemic.

The confirmed speakers are as follows. See more teachers and take advantage of early registration.

April Adams, PharmD, Senior Director of Field Medical Affairs, Bristol Myers Squibb

Maarten Beekman, MD, Medical Director, Internal Consultant to International Medical Respiratory & Immunology, AstraZeneca

Kathy Belk, Vice President, Real World Evidence and Data Analytics, Healthcare Consultancy Group

Sonal Bhatia, MD, Chief Medical Officer, Rare Diseases, Pfizer

Chris Blanchette, PhD, MBA, Vice President and Head, Clinical Development and Outcomes Research, Novo Nordisk

Leigh Boehmer, MD, Chief Medical Officer, Association of Community Cancer Centers

Sarah Burns, Director of Data Visualization, Global Science Communications, Eli Lilly & Company

Steve Casey, Managing Partner, OmniHealthcare Communications LLC

Laura Clark, Senior Scientist, Real-World Evidence and Analytics, Healthcare Consultancy Group

Deborah Crawford, MSL Team and Therapeutics Manager, Teva Pharmaceuticals

Omar Dabbous, MD, MPH, VP, Global HEOR and Real World Evidence, AveXis, Inc., a Novartis company

Alex Derchak, PhD, Executive Director, External Engagement, Amgen

Ivan Desviat, MBA, CHCP, Director, Excellence in Medical Education, AbbVie

Mike Devoy, MD, Medical Director, Executive Vice President, Medical Affairs and Pharmacovigilance, Bayer

Luca Dezzani, MD, Franchise Manager, U.S. Immuno-Oncology Medical Affairs, AstraZeneca

Aalap Dighe, Partner, McKinsey and Company

Elvira Dsouza, President, Cactus Life Sciences

Danie du Plessis, MD, MBA, Executive Vice President, Medical Affairs, Kyowa Kirin International

Catherine Duehren, DNP, RN, Director, Clinical Solutions, Medical Affairs and IT, Hillrom

Sissy Easo-Joseph, MS, Ph.D, Director, Scientific Communications, Migraine and Headache, Teva Pharmaceuticals

Laura Engles-Horton, PharmD, Director, Medical Learning and Development, Bayer

Matthew Frankel, MD, Vice President, Clinical Development and Medical Affairs, Specialty Care, Boehringer Ingelheim

Sarah Funderburk, PhD, CMPP, SVP, Senior Director of Medical Strategy, Caudex, at McCann Health Company

Wendy Fraser, Executive Director, Field Medical Center of Excellence & Scientific Training, Merck & Co.

Alba Garcia Estella, Partner, McKinsey and Company

Meg Glancey, MSPH, Clinical Advisory Director, Marimac Insight

Eleonora Goldberg, Executive Director, Global Field Medical Excellence, Amgen

Heather Goolsby, PhD, Director, Medical Learning and Development, Bayer

Gokul Gopalan, Vice President, Global Medical Affairs, Vertex Pharmaceuticals

Robert Groebel, Vice President of Global Medical Strategy, Monocl

Rebecca Harmon, PharmD, MBA, Senior Advisor / COO, Diabetes Development, Eli Lilly and Company

Rachel Hatfield, Ph.D, Managing Partner, MEDiSTRAVA Consulting

Ross Heritage, CTO, Pharmaspectra

Donna Holder, Senior Director, MSL Global Excellence

Tony Hooper, independent director

Emily Howmann, Ph.D, Senior Medical Strategy Manager, Envision Pharma

Barb Jones, PhD, SVP, Scientific Operations and Regulatory Affairs, Vyant Bio

Marieke Jonkman, PharmD, PCC, Executive Coach in Medical Affairs, The Medical Affairs Leadership Institute

Deirdre Jordan, MSc, Head of Global Medical Affairs Excellence, Sandoz

Renu Juneja, PhD, Head, Scientific Evidence and Communications, Oncology US Medical Affairs, Janssen

Aaron Kamauu, Managing Director, HCG Luminary Expert, Ikaika Health

Wendy Kampman, Head of Global Medical Franchise, General Practice and Infectious Diseases, Regeneron

David Kelaher, Chief Medical Officer, Pharmaspectra

Jessica Klein, Director, Global Rare Diseases, Ipsen

Simon Kyaga, MD, PhD, Global Medical Director, Alzheimer’s Disease, Europe Canada and Partner Markets (ECP), Biogen

Suzanna Lawrence, Global Health Medical, Amplity Health

Matt Lewis, Global Director of Medical Analysis and Innovation, MEDiSTRAVA

Grace Macalino, Ph.D, CEO and General Manager of Professional Practices, Marimac Insights

Lizandra Marcondes, Head of Averitas Medical Affairs, Grünenthal Group

Canter Martin, Executive Vice President and General Manager, Healthcare Consultancy Group

Pamela Mason, BS, CHCP, FACEHP, ATSF, Senior Director, Office of Medical Education Grants, AstraZeneca

Yasamin Mir-Shekari, Global Head, Medical Strategy, Envision Pharma Group

Mark Monane, MD, MBA, ACC, Medical Director, Monane Group Clinical Consulting

Lori Mouser, Global Manager, Medical Customer Engagement, Roche

Jean-Jacques Murama, BSC, MBA, Medical Education Affairs Education, Launch and TL Engagement Global Medical Affairs Office, Eli Lilly and Company

Jameel Nazir, PhD, Global Head, HEOR, Sobi

Ali Nourbaksh, Senior Director of Medical Affairs, Otsuka

Paul O’Grady, PhD, Head of Scientific Communications and Global Oncology Strategy, GSK

Lucy Perez, Senior Partner, McKinsey and Company

Frank Pompilio, Vice-President, Medical Affairs, Arcutis Biotherapeutics

Olga Salvidio, Director, Global Medical Education and Academic Organization Relations, Merck

Jessica Santos, Global Director of Compliance and Quality, Kantar Health

Monicca Shanthanelson, Ph.D, CMPP, VP Global Medical Consulting, Veeva Systems

Marija Simin Geertsen, MD, PhD, VP, Medical Affairs, Lundbeck

Surinder Singh, Suringer Singh, Vice President, Head of US Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Inc.

Cassie Stox, Senior Director, Media Strategy and Audience Information, Medthink

Richard Swank, Head of US Medical Capabilities, Amgen

Marco Taglietti, MD, President and CEO, SYNEXIS

Cameron Tew, Vice President of Account Management, MedEvoke

Mondher Toumi, professor of public health, Aix-Marseille University; President and CEO, CreativCeutical

Russell Traynor, Head of Product Strategy and Management, Envision Pharma Group

Carlos Urrea, MD, MPH, VP, Medical and Informatics Affairs, Hillrom

Anna Walz, Founder and CEO Emeritus, MedEvoke and Senior Strategic Advisor, MEDiSTRAVA

Johnathan Wert, MD, Senior Vice President, Medical Strategy, Healthcare Consulting Group

Ann Westra, Senior Knowledge Expert, McKinsey and Company

About MAPS
MAPS is the world’s premier nonprofit medical business organization for medical business professionals by medical business professionals across all different levels of experience / specialty to engage, empower and educate. With more than 6,300 Medical Affairs members from more than 220 companies around the world, MAPS is transforming the profession of Medical Affairs to increase its value to patients, healthcare professionals and other decision makers.

Garth Sundem
Professional Society of Medical Affairs (MAPS)
+1 805-559-2023
write us here
Visit us on social networks:
LinkedIn


Comments are closed.